# Dizal Pharma

**Canonical:** https://apis.io/providers/dizal-pharma/  
**Website:** https://www.dizalpharma.com  
**APIs profiled:** 0

Dizal Pharma (Dizal (Jiangsu) Pharmaceutical Co., Ltd.) is a clinical-stage biopharmaceutical company focused on discovering and developing novel medicines in oncology and immunology. Originating in 2017 from research capabilities established in China, the company operates research and development across Shanghai and Wuxi (Jiangsu), China, and is listed on the Shanghai Stock Exchange STAR Market (ticker 688192). Dizal's most advanced programs include sunvozertinib (DZD9008), an oral EGFR exon 20 insertion inhibitor for non-small cell lung cancer marketed as Zegfrovy, and golidocitinib (DZD4205), a selective JAK1 inhibitor developed for relapsed/refractory peripheral T-cell lymphoma. Dizal Pharma was surfaced in the API Evangelist network as a portfolio company of the venture firm HongShan (formerly Sequoia Capital China). As a pharmaceutical developer it publishes a corporate marketing and investor-facing website but does not expose a public developer platform, API program, or machine-readable API artifacts at this time; this profile captures the company identity for the network.

## Kin Score — 3.8 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 3.8).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Dizal Pharma Domain Security** — TLSv1.2

## Tags

Company, Healthcare, Pharmaceuticals, Biotechnology, Oncology, Immunology, Drug Development, Clinical Research, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/dizal-pharma/). Scores are computed from the provider's own public artifacts under a published rubric.